SETDB1 and liver cancer: At present, SETDB1 inhibition has been shown to significantly improve the sensitivity of liver cancer radiation therapy, so combining SETDB1 inhibition with the currently used liver cancer treatment methods, such as chemotherapy, radiotherapy or gene therapy, may have a good therapeutic effect.